
Ganciclovir Injection
| Product/Composition:- | Ganciclovir Injection |
|---|---|
| Strength:- | 250mg, 500mg |
| Form | Injection |
| Production Capacity | 1 Million Injection/Month |
| Therapeutic use | Anti Cancer |
| Package Insert/Leaflet | Available upon request |
Ganciclovir Injection
-
Type: Antiviral medication
-
Drug Class: Guanosine analog / Antiviral agent
-
Form: Lyophilized powder or solution for intravenous (IV) infusion
How It Works
-
Ganciclovir is phosphorylated inside infected cells to its active triphosphate form.
-
It inhibits viral DNA polymerase, preventing viral DNA replication.
-
This action stops the multiplication of cytomegalovirus (CMV) and other herpesviruses.
Common Uses
Ganciclovir injection is mainly used for serious CMV infections, including:
-
CMV retinitis in immunocompromised patients (e.g., HIV/AIDS)
-
CMV pneumonia, colitis, or esophagitis in transplant recipients
-
CMV prophylaxis after organ or bone marrow transplantation
-
Treatment of severe infections caused by other herpesviruses (off-label, in select cases)
Advantages
-
Highly effective against CMV compared to acyclovir
-
Can be used as prophylaxis to prevent CMV disease in high-risk transplant patients
-
Can later be switched to oral valganciclovir for long-term maintenance therapy
Possible Side Effects
Common:
-
Bone marrow suppression (neutropenia, anemia, thrombocytopenia)
-
Fever, fatigue
-
Nausea, diarrhea
Serious / Important:
-
Severe neutropenia (risk of life-threatening infections)
-
Kidney toxicity (requires dose adjustment)
-
CNS effects: confusion, seizures (rare)
-
Potential reproductive toxicity (may cause infertility or birth defects)
Precautions
-
Regular monitoring of blood counts is essential during therapy
-
Adjust dose in renal impairment to avoid accumulation and toxicity
-
Avoid use in pregnancy unless absolutely necessary (teratogenic potential)